Helicobacter pylori, gastrointestinal microbiota, and immunotherapy

Helicobacter. 2023 Feb;28(1):e12942. doi: 10.1111/hel.12942. Epub 2022 Dec 7.

Authors

Zhongxue Han^{1

2

3}, Yueyue Li^{1

2

3}, Yanqing Li^{1

2

3}

Affiliations

¹ Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
² Laboratory of Translational Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
³ Robot Engineering Laboratory for Precise Diagnosis and Therapy of GI Tumor, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

PMID: 36478623
DOI: 10.1111/hel.12942

No abstract available

Publication types

Letter
Comment

MeSH terms

Gastrointestinal Microbiome*
Helicobacter Infections* / drug therapy
Helicobacter pylori*
Humans
Immunotherapy
Stomach